nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Diclofenamide—glaucoma	0.0815	0.167	CbGbCtD
Bexarotene—CYP2C9—Dorzolamide—glaucoma	0.0788	0.162	CbGbCtD
Bexarotene—CYP2C9—Methazolamide—glaucoma	0.0702	0.144	CbGbCtD
Bexarotene—CYP3A4—Pilocarpine—glaucoma	0.0604	0.124	CbGbCtD
Bexarotene—CYP3A4—Brinzolamide—glaucoma	0.0474	0.0973	CbGbCtD
Bexarotene—CYP3A4—Dorzolamide—glaucoma	0.0458	0.094	CbGbCtD
Bexarotene—CYP3A4—Methazolamide—glaucoma	0.0408	0.0838	CbGbCtD
Bexarotene—CYP3A4—Acetazolamide—glaucoma	0.0326	0.067	CbGbCtD
Bexarotene—CYP3A4—Clonidine—glaucoma	0.0295	0.0606	CbGbCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00187	0.0524	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00176	0.0493	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—NR3C1—glaucoma	0.00102	0.0286	CbGpPWpGaD
Bexarotene—RXRA—Endogenous sterols—CYP1B1—glaucoma	0.00101	0.0283	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.000972	0.0272	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—NR3C1—glaucoma	0.000962	0.0269	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.000919	0.0257	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.000914	0.0255	CbGpPWpGaD
Bexarotene—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00088	0.0246	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000815	0.0228	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000809	0.0226	CbGpPWpGaD
Bexarotene—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000801	0.0224	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000784	0.0219	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—NR3C1—glaucoma	0.000777	0.0217	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000761	0.0213	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000737	0.0206	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00057	0.0159	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000536	0.015	CbGpPWpGaD
Bexarotene—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000528	0.0148	CbGpPWpGaD
Bexarotene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000517	0.0144	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—glaucoma	0.000512	0.0143	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—NR3C1—glaucoma	0.000502	0.014	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.000476	0.0133	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000471	0.0132	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC6A13—glaucoma	0.000455	0.0127	CbGpPWpGaD
Bexarotene—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000407	0.0114	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000396	0.0111	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000384	0.0107	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—NR3C1—glaucoma	0.000383	0.0107	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000381	0.0107	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TXN—glaucoma	0.000374	0.0105	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—NR3C1—glaucoma	0.000373	0.0104	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—FAS—glaucoma	0.000371	0.0104	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC6A1—glaucoma	0.000333	0.00931	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PEX19—glaucoma	0.000324	0.00904	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000319	0.00893	CbGpPWpGaD
Bexarotene—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000304	0.00848	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—ABCA1—glaucoma	0.00029	0.0081	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000284	0.00793	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000279	0.00781	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000277	0.00773	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB2—glaucoma	0.000272	0.00759	CbGpPWpGaD
Bexarotene—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000268	0.0075	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GSTT1—glaucoma	0.000254	0.00711	CbGpPWpGaD
Bexarotene—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000243	0.00678	CbGpPWpGaD
Bexarotene—Dyspnoea—Pilocarpine—glaucoma	0.000236	0.000495	CcSEcCtD
Bexarotene—Pain—Brinzolamide—glaucoma	0.000236	0.000494	CcSEcCtD
Bexarotene—Somnolence—Pilocarpine—glaucoma	0.000236	0.000494	CcSEcCtD
Bexarotene—Angiopathy—Betaxolol—glaucoma	0.000235	0.000493	CcSEcCtD
Bexarotene—Pruritus—Bimatoprost—glaucoma	0.000235	0.000492	CcSEcCtD
Bexarotene—Diarrhoea—Apraclonidine—glaucoma	0.000234	0.00049	CcSEcCtD
Bexarotene—Malaise—Clonidine—glaucoma	0.000234	0.00049	CcSEcCtD
Bexarotene—Dyspepsia—Pilocarpine—glaucoma	0.000233	0.000489	CcSEcCtD
Bexarotene—Chills—Betaxolol—glaucoma	0.000233	0.000488	CcSEcCtD
Bexarotene—Syncope—Clonidine—glaucoma	0.000232	0.000487	CcSEcCtD
Bexarotene—Arrhythmia—Betaxolol—glaucoma	0.000232	0.000485	CcSEcCtD
Bexarotene—Feeling abnormal—Dorzolamide—glaucoma	0.000231	0.000484	CcSEcCtD
Bexarotene—Decreased appetite—Pilocarpine—glaucoma	0.00023	0.000483	CcSEcCtD
Bexarotene—Feeling abnormal—Travoprost—glaucoma	0.00023	0.000482	CcSEcCtD
Bexarotene—Conjunctivitis—Timolol—glaucoma	0.000229	0.000481	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dorzolamide—glaucoma	0.000229	0.000481	CcSEcCtD
Bexarotene—Alopecia—Betaxolol—glaucoma	0.000229	0.00048	CcSEcCtD
Bexarotene—Palpitations—Clonidine—glaucoma	0.000229	0.00048	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000229	0.000479	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000229	0.00639	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Travoprost—glaucoma	0.000228	0.000479	CcSEcCtD
Bexarotene—Loss of consciousness—Clonidine—glaucoma	0.000228	0.000478	CcSEcCtD
Bexarotene—Feeling abnormal—Brinzolamide—glaucoma	0.000227	0.000476	CcSEcCtD
Bexarotene—Pain—Pilocarpine—glaucoma	0.000227	0.000475	CcSEcCtD
Bexarotene—Constipation—Pilocarpine—glaucoma	0.000227	0.000475	CcSEcCtD
Bexarotene—Cough—Clonidine—glaucoma	0.000226	0.000474	CcSEcCtD
Bexarotene—Sweating—Timolol—glaucoma	0.000226	0.000474	CcSEcCtD
Bexarotene—Dizziness—Apraclonidine—glaucoma	0.000226	0.000474	CcSEcCtD
Bexarotene—Erythema—Betaxolol—glaucoma	0.000226	0.000473	CcSEcCtD
Bexarotene—Malnutrition—Betaxolol—glaucoma	0.000226	0.000473	CcSEcCtD
Bexarotene—Epistaxis—Timolol—glaucoma	0.000223	0.000466	CcSEcCtD
Bexarotene—Abdominal pain—Dorzolamide—glaucoma	0.000222	0.000465	CcSEcCtD
Bexarotene—Body temperature increased—Dorzolamide—glaucoma	0.000222	0.000465	CcSEcCtD
Bexarotene—Tension—Betaxolol—glaucoma	0.000221	0.000464	CcSEcCtD
Bexarotene—Sinusitis—Timolol—glaucoma	0.000221	0.000464	CcSEcCtD
Bexarotene—Dysgeusia—Betaxolol—glaucoma	0.000221	0.000463	CcSEcCtD
Bexarotene—Arthralgia—Clonidine—glaucoma	0.000221	0.000463	CcSEcCtD
Bexarotene—Chest pain—Clonidine—glaucoma	0.000221	0.000463	CcSEcCtD
Bexarotene—Abdominal pain—Travoprost—glaucoma	0.000221	0.000463	CcSEcCtD
Bexarotene—Anxiety—Clonidine—glaucoma	0.00022	0.000461	CcSEcCtD
Bexarotene—Asthenia—Acetazolamide—glaucoma	0.000219	0.00046	CcSEcCtD
Bexarotene—Dizziness—Bimatoprost—glaucoma	0.000219	0.00046	CcSEcCtD
Bexarotene—Nervousness—Betaxolol—glaucoma	0.000219	0.000459	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000219	0.000459	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000219	0.00611	CbGpPWpGaD
Bexarotene—Feeling abnormal—Pilocarpine—glaucoma	0.000218	0.000458	CcSEcCtD
Bexarotene—Discomfort—Clonidine—glaucoma	0.000218	0.000457	CcSEcCtD
Bexarotene—Vomiting—Apraclonidine—glaucoma	0.000217	0.000456	CcSEcCtD
Bexarotene—Muscle spasms—Betaxolol—glaucoma	0.000217	0.000455	CcSEcCtD
Bexarotene—Gastrointestinal pain—Pilocarpine—glaucoma	0.000217	0.000454	CcSEcCtD
Bexarotene—Hypersensitivity—Brimonidine—glaucoma	0.000216	0.000453	CcSEcCtD
Bexarotene—Dry mouth—Clonidine—glaucoma	0.000216	0.000452	CcSEcCtD
Bexarotene—Dermatitis—Apraclonidine—glaucoma	0.000215	0.000452	CcSEcCtD
Bexarotene—Headache—Apraclonidine—glaucoma	0.000214	0.000449	CcSEcCtD
Bexarotene—Confusional state—Clonidine—glaucoma	0.000213	0.000447	CcSEcCtD
Bexarotene—Rhinitis—Timolol—glaucoma	0.000212	0.000445	CcSEcCtD
Bexarotene—Oedema—Clonidine—glaucoma	0.000212	0.000443	CcSEcCtD
Bexarotene—Asthenia—Brimonidine—glaucoma	0.000211	0.000442	CcSEcCtD
Bexarotene—Infection—Clonidine—glaucoma	0.00021	0.000441	CcSEcCtD
Bexarotene—Abdominal pain—Pilocarpine—glaucoma	0.000209	0.000439	CcSEcCtD
Bexarotene—Body temperature increased—Pilocarpine—glaucoma	0.000209	0.000439	CcSEcCtD
Bexarotene—Ill-defined disorder—Betaxolol—glaucoma	0.000209	0.000439	CcSEcCtD
Bexarotene—Diarrhoea—Acetazolamide—glaucoma	0.000209	0.000439	CcSEcCtD
Bexarotene—Rash—Bimatoprost—glaucoma	0.000209	0.000438	CcSEcCtD
Bexarotene—Dermatitis—Bimatoprost—glaucoma	0.000209	0.000438	CcSEcCtD
Bexarotene—Oedema peripheral—Timolol—glaucoma	0.000209	0.000437	CcSEcCtD
Bexarotene—Anaemia—Betaxolol—glaucoma	0.000209	0.000437	CcSEcCtD
Bexarotene—Shock—Clonidine—glaucoma	0.000208	0.000436	CcSEcCtD
Bexarotene—Connective tissue disorder—Timolol—glaucoma	0.000208	0.000436	CcSEcCtD
Bexarotene—Pruritus—Brimonidine—glaucoma	0.000208	0.000435	CcSEcCtD
Bexarotene—Headache—Bimatoprost—glaucoma	0.000208	0.000435	CcSEcCtD
Bexarotene—Nervous system disorder—Clonidine—glaucoma	0.000208	0.000435	CcSEcCtD
Bexarotene—Thrombocytopenia—Clonidine—glaucoma	0.000207	0.000434	CcSEcCtD
Bexarotene—Hypersensitivity—Dorzolamide—glaucoma	0.000207	0.000433	CcSEcCtD
Bexarotene—Tachycardia—Clonidine—glaucoma	0.000207	0.000433	CcSEcCtD
Bexarotene—Hypersensitivity—Travoprost—glaucoma	0.000206	0.000431	CcSEcCtD
Bexarotene—Skin disorder—Clonidine—glaucoma	0.000206	0.000431	CcSEcCtD
Bexarotene—Hyperhidrosis—Clonidine—glaucoma	0.000205	0.000429	CcSEcCtD
Bexarotene—Malaise—Betaxolol—glaucoma	0.000204	0.000427	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000203	0.00568	CbGpPWpGaD
Bexarotene—Nausea—Apraclonidine—glaucoma	0.000203	0.000426	CcSEcCtD
Bexarotene—Hypersensitivity—Brinzolamide—glaucoma	0.000203	0.000426	CcSEcCtD
Bexarotene—Vertigo—Betaxolol—glaucoma	0.000203	0.000425	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—CYP1B1—glaucoma	0.000203	0.00566	CbGpPWpGaD
Bexarotene—Syncope—Betaxolol—glaucoma	0.000202	0.000424	CcSEcCtD
Bexarotene—Dizziness—Acetazolamide—glaucoma	0.000202	0.000424	CcSEcCtD
Bexarotene—Anorexia—Clonidine—glaucoma	0.000202	0.000423	CcSEcCtD
Bexarotene—Asthenia—Dorzolamide—glaucoma	0.000201	0.000422	CcSEcCtD
Bexarotene—Asthenia—Travoprost—glaucoma	0.0002	0.00042	CcSEcCtD
Bexarotene—Palpitations—Betaxolol—glaucoma	0.000199	0.000418	CcSEcCtD
Bexarotene—Pruritus—Dorzolamide—glaucoma	0.000198	0.000416	CcSEcCtD
Bexarotene—Loss of consciousness—Betaxolol—glaucoma	0.000198	0.000416	CcSEcCtD
Bexarotene—Eye disorder—Timolol—glaucoma	0.000198	0.000415	CcSEcCtD
Bexarotene—Asthenia—Brinzolamide—glaucoma	0.000198	0.000415	CcSEcCtD
Bexarotene—Pruritus—Travoprost—glaucoma	0.000198	0.000414	CcSEcCtD
Bexarotene—Tinnitus—Timolol—glaucoma	0.000197	0.000414	CcSEcCtD
Bexarotene—Cough—Betaxolol—glaucoma	0.000197	0.000413	CcSEcCtD
Bexarotene—Nausea—Bimatoprost—glaucoma	0.000197	0.000413	CcSEcCtD
Bexarotene—Cardiac disorder—Timolol—glaucoma	0.000197	0.000412	CcSEcCtD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000195	0.00546	CbGpPWpGaD
Bexarotene—Hypersensitivity—Pilocarpine—glaucoma	0.000195	0.000409	CcSEcCtD
Bexarotene—Pruritus—Brinzolamide—glaucoma	0.000195	0.000409	CcSEcCtD
Bexarotene—Vomiting—Acetazolamide—glaucoma	0.000195	0.000408	CcSEcCtD
Bexarotene—Dizziness—Brimonidine—glaucoma	0.000194	0.000407	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Clonidine—glaucoma	0.000193	0.000404	CcSEcCtD
Bexarotene—Angiopathy—Timolol—glaucoma	0.000192	0.000403	CcSEcCtD
Bexarotene—Arthralgia—Betaxolol—glaucoma	0.000192	0.000403	CcSEcCtD
Bexarotene—Chest pain—Betaxolol—glaucoma	0.000192	0.000403	CcSEcCtD
Bexarotene—Myalgia—Betaxolol—glaucoma	0.000192	0.000403	CcSEcCtD
Bexarotene—Diarrhoea—Dorzolamide—glaucoma	0.000192	0.000402	CcSEcCtD
Bexarotene—Headache—Acetazolamide—glaucoma	0.000192	0.000402	CcSEcCtD
Bexarotene—Anxiety—Betaxolol—glaucoma	0.000191	0.000401	CcSEcCtD
Bexarotene—Insomnia—Clonidine—glaucoma	0.000191	0.000401	CcSEcCtD
Bexarotene—Diarrhoea—Travoprost—glaucoma	0.000191	0.0004	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000191	0.0004	CcSEcCtD
Bexarotene—Asthenia—Pilocarpine—glaucoma	0.00019	0.000398	CcSEcCtD
Bexarotene—Paraesthesia—Clonidine—glaucoma	0.00019	0.000398	CcSEcCtD
Bexarotene—Discomfort—Betaxolol—glaucoma	0.00019	0.000398	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000189	0.00529	CbGpPWpGaD
Bexarotene—Arrhythmia—Timolol—glaucoma	0.000189	0.000397	CcSEcCtD
Bexarotene—Dyspnoea—Clonidine—glaucoma	0.000189	0.000395	CcSEcCtD
Bexarotene—Diarrhoea—Brinzolamide—glaucoma	0.000189	0.000395	CcSEcCtD
Bexarotene—Somnolence—Clonidine—glaucoma	0.000188	0.000394	CcSEcCtD
Bexarotene—Dry mouth—Betaxolol—glaucoma	0.000188	0.000394	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—NR3C1—glaucoma	0.000187	0.00524	CbGpPWpGaD
Bexarotene—Pruritus—Pilocarpine—glaucoma	0.000187	0.000393	CcSEcCtD
Bexarotene—Alopecia—Timolol—glaucoma	0.000187	0.000392	CcSEcCtD
Bexarotene—Confusional state—Betaxolol—glaucoma	0.000186	0.000389	CcSEcCtD
Bexarotene—Dizziness—Dorzolamide—glaucoma	0.000185	0.000389	CcSEcCtD
Bexarotene—Rash—Brimonidine—glaucoma	0.000185	0.000388	CcSEcCtD
Bexarotene—Dermatitis—Brimonidine—glaucoma	0.000185	0.000388	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—GSTM1—glaucoma	0.000185	0.00516	CbGpPWpGaD
Bexarotene—Dizziness—Travoprost—glaucoma	0.000185	0.000387	CcSEcCtD
Bexarotene—Erythema—Timolol—glaucoma	0.000184	0.000386	CcSEcCtD
Bexarotene—Malnutrition—Timolol—glaucoma	0.000184	0.000386	CcSEcCtD
Bexarotene—Oedema—Betaxolol—glaucoma	0.000184	0.000386	CcSEcCtD
Bexarotene—Headache—Brimonidine—glaucoma	0.000184	0.000386	CcSEcCtD
Bexarotene—Decreased appetite—Clonidine—glaucoma	0.000184	0.000386	CcSEcCtD
Bexarotene—Infection—Betaxolol—glaucoma	0.000183	0.000384	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Clonidine—glaucoma	0.000183	0.000383	CcSEcCtD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000182	0.0051	CbGpPWpGaD
Bexarotene—Fatigue—Clonidine—glaucoma	0.000182	0.000382	CcSEcCtD
Bexarotene—Dizziness—Brinzolamide—glaucoma	0.000182	0.000382	CcSEcCtD
Bexarotene—Nausea—Acetazolamide—glaucoma	0.000182	0.000381	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—FAS—glaucoma	0.000182	0.00508	CbGpPWpGaD
Bexarotene—Diarrhoea—Pilocarpine—glaucoma	0.000181	0.00038	CcSEcCtD
Bexarotene—Shock—Betaxolol—glaucoma	0.000181	0.00038	CcSEcCtD
Bexarotene—Tension—Timolol—glaucoma	0.000181	0.000379	CcSEcCtD
Bexarotene—Pain—Clonidine—glaucoma	0.000181	0.000379	CcSEcCtD
Bexarotene—Constipation—Clonidine—glaucoma	0.000181	0.000379	CcSEcCtD
Bexarotene—Nervous system disorder—Betaxolol—glaucoma	0.000181	0.000379	CcSEcCtD
Bexarotene—Dysgeusia—Timolol—glaucoma	0.000181	0.000378	CcSEcCtD
Bexarotene—Thrombocytopenia—Betaxolol—glaucoma	0.00018	0.000378	CcSEcCtD
Bexarotene—Tachycardia—Betaxolol—glaucoma	0.00018	0.000377	CcSEcCtD
Bexarotene—Nervousness—Timolol—glaucoma	0.000179	0.000375	CcSEcCtD
Bexarotene—Skin disorder—Betaxolol—glaucoma	0.000179	0.000375	CcSEcCtD
Bexarotene—Vomiting—Dorzolamide—glaucoma	0.000178	0.000374	CcSEcCtD
Bexarotene—RXRA—Metabolism—CA5A—glaucoma	0.000178	0.00498	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NARFL—glaucoma	0.000178	0.00498	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Betaxolol—glaucoma	0.000178	0.000373	CcSEcCtD
Bexarotene—Rash—Dorzolamide—glaucoma	0.000177	0.000371	CcSEcCtD
Bexarotene—Dermatitis—Dorzolamide—glaucoma	0.000177	0.00037	CcSEcCtD
Bexarotene—Rash—Travoprost—glaucoma	0.000176	0.000369	CcSEcCtD
Bexarotene—Dermatitis—Travoprost—glaucoma	0.000176	0.000369	CcSEcCtD
Bexarotene—Headache—Dorzolamide—glaucoma	0.000176	0.000368	CcSEcCtD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000176	0.00491	CbGpPWpGaD
Bexarotene—Anorexia—Betaxolol—glaucoma	0.000176	0.000368	CcSEcCtD
Bexarotene—Vomiting—Brinzolamide—glaucoma	0.000175	0.000367	CcSEcCtD
Bexarotene—Dizziness—Pilocarpine—glaucoma	0.000175	0.000367	CcSEcCtD
Bexarotene—Headache—Travoprost—glaucoma	0.000175	0.000367	CcSEcCtD
Bexarotene—Nausea—Brimonidine—glaucoma	0.000174	0.000366	CcSEcCtD
Bexarotene—Feeling abnormal—Clonidine—glaucoma	0.000174	0.000365	CcSEcCtD
Bexarotene—Rash—Brinzolamide—glaucoma	0.000174	0.000364	CcSEcCtD
Bexarotene—Dermatitis—Brinzolamide—glaucoma	0.000174	0.000364	CcSEcCtD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000173	0.00485	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Clonidine—glaucoma	0.000173	0.000363	CcSEcCtD
Bexarotene—Headache—Brinzolamide—glaucoma	0.000173	0.000362	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00017	0.00476	CbGpPWpGaD
Bexarotene—Vomiting—Pilocarpine—glaucoma	0.000168	0.000353	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000168	0.000352	CcSEcCtD
Bexarotene—Abdominal pain—Clonidine—glaucoma	0.000167	0.000351	CcSEcCtD
Bexarotene—Body temperature increased—Clonidine—glaucoma	0.000167	0.000351	CcSEcCtD
Bexarotene—Rash—Pilocarpine—glaucoma	0.000167	0.00035	CcSEcCtD
Bexarotene—Dermatitis—Pilocarpine—glaucoma	0.000167	0.00035	CcSEcCtD
Bexarotene—Insomnia—Betaxolol—glaucoma	0.000167	0.000349	CcSEcCtD
Bexarotene—Nausea—Dorzolamide—glaucoma	0.000167	0.000349	CcSEcCtD
Bexarotene—Headache—Pilocarpine—glaucoma	0.000166	0.000348	CcSEcCtD
Bexarotene—Nausea—Travoprost—glaucoma	0.000166	0.000348	CcSEcCtD
Bexarotene—Vertigo—Timolol—glaucoma	0.000166	0.000347	CcSEcCtD
Bexarotene—Paraesthesia—Betaxolol—glaucoma	0.000165	0.000347	CcSEcCtD
Bexarotene—Syncope—Timolol—glaucoma	0.000165	0.000347	CcSEcCtD
Bexarotene—Dyspnoea—Betaxolol—glaucoma	0.000164	0.000344	CcSEcCtD
Bexarotene—Nausea—Brinzolamide—glaucoma	0.000164	0.000343	CcSEcCtD
Bexarotene—Palpitations—Timolol—glaucoma	0.000163	0.000342	CcSEcCtD
Bexarotene—Dyspepsia—Betaxolol—glaucoma	0.000162	0.00034	CcSEcCtD
Bexarotene—Loss of consciousness—Timolol—glaucoma	0.000162	0.00034	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—GSTM1—glaucoma	0.000162	0.00453	CbGpPWpGaD
Bexarotene—Cough—Timolol—glaucoma	0.000161	0.000337	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—NCK2—glaucoma	0.000161	0.00449	CbGpPWpGaD
Bexarotene—Decreased appetite—Betaxolol—glaucoma	0.00016	0.000336	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000159	0.00445	CbGpPWpGaD
Bexarotene—Hypertension—Timolol—glaucoma	0.000159	0.000334	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betaxolol—glaucoma	0.000159	0.000333	CcSEcCtD
Bexarotene—Fatigue—Betaxolol—glaucoma	0.000159	0.000333	CcSEcCtD
Bexarotene—Pain—Betaxolol—glaucoma	0.000158	0.00033	CcSEcCtD
Bexarotene—Constipation—Betaxolol—glaucoma	0.000158	0.00033	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—TNF—glaucoma	0.000157	0.0044	CbGpPWpGaD
Bexarotene—Nausea—Pilocarpine—glaucoma	0.000157	0.00033	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000157	0.00439	CbGpPWpGaD
Bexarotene—Chest pain—Timolol—glaucoma	0.000157	0.000329	CcSEcCtD
Bexarotene—Arthralgia—Timolol—glaucoma	0.000157	0.000329	CcSEcCtD
Bexarotene—Myalgia—Timolol—glaucoma	0.000157	0.000329	CcSEcCtD
Bexarotene—Anxiety—Timolol—glaucoma	0.000156	0.000328	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000156	0.00436	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000156	0.000327	CcSEcCtD
Bexarotene—Hypersensitivity—Clonidine—glaucoma	0.000156	0.000327	CcSEcCtD
Bexarotene—Discomfort—Timolol—glaucoma	0.000155	0.000325	CcSEcCtD
Bexarotene—Dry mouth—Timolol—glaucoma	0.000154	0.000322	CcSEcCtD
Bexarotene—Asthenia—Clonidine—glaucoma	0.000152	0.000318	CcSEcCtD
Bexarotene—Feeling abnormal—Betaxolol—glaucoma	0.000152	0.000318	CcSEcCtD
Bexarotene—Confusional state—Timolol—glaucoma	0.000152	0.000318	CcSEcCtD
Bexarotene—Oedema—Timolol—glaucoma	0.00015	0.000315	CcSEcCtD
Bexarotene—Pruritus—Clonidine—glaucoma	0.00015	0.000314	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—CDKN2B—glaucoma	0.00015	0.00418	CbGpPWpGaD
Bexarotene—Infection—Timolol—glaucoma	0.00015	0.000313	CcSEcCtD
Bexarotene—Shock—Timolol—glaucoma	0.000148	0.00031	CcSEcCtD
Bexarotene—Nervous system disorder—Timolol—glaucoma	0.000148	0.000309	CcSEcCtD
Bexarotene—Skin disorder—Timolol—glaucoma	0.000146	0.000306	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000146	0.00408	CbGpPWpGaD
Bexarotene—Body temperature increased—Betaxolol—glaucoma	0.000146	0.000305	CcSEcCtD
Bexarotene—Hyperhidrosis—Timolol—glaucoma	0.000145	0.000305	CcSEcCtD
Bexarotene—Diarrhoea—Clonidine—glaucoma	0.000145	0.000303	CcSEcCtD
Bexarotene—Anorexia—Timolol—glaucoma	0.000143	0.000301	CcSEcCtD
Bexarotene—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000143	0.004	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000142	0.00398	CbGpPWpGaD
Bexarotene—Dizziness—Clonidine—glaucoma	0.00014	0.000293	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—NR3C1—glaucoma	0.00014	0.00391	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Timolol—glaucoma	0.000137	0.000287	CcSEcCtD
Bexarotene—Insomnia—Timolol—glaucoma	0.000136	0.000285	CcSEcCtD
Bexarotene—Hypersensitivity—Betaxolol—glaucoma	0.000136	0.000284	CcSEcCtD
Bexarotene—Paraesthesia—Timolol—glaucoma	0.000135	0.000283	CcSEcCtD
Bexarotene—Vomiting—Clonidine—glaucoma	0.000135	0.000282	CcSEcCtD
Bexarotene—Dyspnoea—Timolol—glaucoma	0.000134	0.000281	CcSEcCtD
Bexarotene—Somnolence—Timolol—glaucoma	0.000134	0.00028	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000134	0.00373	CbGpPWpGaD
Bexarotene—Rash—Clonidine—glaucoma	0.000133	0.00028	CcSEcCtD
Bexarotene—Dermatitis—Clonidine—glaucoma	0.000133	0.000279	CcSEcCtD
Bexarotene—Headache—Clonidine—glaucoma	0.000133	0.000278	CcSEcCtD
Bexarotene—Dyspepsia—Timolol—glaucoma	0.000132	0.000278	CcSEcCtD
Bexarotene—Asthenia—Betaxolol—glaucoma	0.000132	0.000277	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—NR3C1—glaucoma	0.000131	0.00367	CbGpPWpGaD
Bexarotene—Decreased appetite—Timolol—glaucoma	0.000131	0.000274	CcSEcCtD
Bexarotene—Pruritus—Betaxolol—glaucoma	0.00013	0.000273	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Timolol—glaucoma	0.00013	0.000272	CcSEcCtD
Bexarotene—Fatigue—Timolol—glaucoma	0.00013	0.000272	CcSEcCtD
Bexarotene—Pain—Timolol—glaucoma	0.000129	0.00027	CcSEcCtD
Bexarotene—Diarrhoea—Betaxolol—glaucoma	0.000126	0.000264	CcSEcCtD
Bexarotene—Nausea—Clonidine—glaucoma	0.000126	0.000263	CcSEcCtD
Bexarotene—Feeling abnormal—Timolol—glaucoma	0.000124	0.00026	CcSEcCtD
Bexarotene—Gastrointestinal pain—Timolol—glaucoma	0.000123	0.000258	CcSEcCtD
Bexarotene—Dizziness—Betaxolol—glaucoma	0.000122	0.000255	CcSEcCtD
Bexarotene—Abdominal pain—Timolol—glaucoma	0.000119	0.000249	CcSEcCtD
Bexarotene—Body temperature increased—Timolol—glaucoma	0.000119	0.000249	CcSEcCtD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000117	0.00328	CbGpPWpGaD
Bexarotene—Vomiting—Betaxolol—glaucoma	0.000117	0.000245	CcSEcCtD
Bexarotene—Rash—Betaxolol—glaucoma	0.000116	0.000243	CcSEcCtD
Bexarotene—Dermatitis—Betaxolol—glaucoma	0.000116	0.000243	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000116	0.00324	CbGpPWpGaD
Bexarotene—Headache—Betaxolol—glaucoma	0.000115	0.000242	CcSEcCtD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000114	0.0032	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000114	0.00319	CbGpPWpGaD
Bexarotene—Hypersensitivity—Timolol—glaucoma	0.000111	0.000232	CcSEcCtD
Bexarotene—Nausea—Betaxolol—glaucoma	0.000109	0.000229	CcSEcCtD
Bexarotene—Asthenia—Timolol—glaucoma	0.000108	0.000226	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000107	0.00298	CbGpPWpGaD
Bexarotene—Pruritus—Timolol—glaucoma	0.000106	0.000223	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—PAX6—glaucoma	0.000104	0.00291	CbGpPWpGaD
Bexarotene—Diarrhoea—Timolol—glaucoma	0.000103	0.000216	CcSEcCtD
Bexarotene—Dizziness—Timolol—glaucoma	9.95e-05	0.000209	CcSEcCtD
Bexarotene—Vomiting—Timolol—glaucoma	9.57e-05	0.000201	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GSTT1—glaucoma	9.49e-05	0.00265	CbGpPWpGaD
Bexarotene—Rash—Timolol—glaucoma	9.49e-05	0.000199	CcSEcCtD
Bexarotene—Dermatitis—Timolol—glaucoma	9.48e-05	0.000199	CcSEcCtD
Bexarotene—Headache—Timolol—glaucoma	9.43e-05	0.000198	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.39e-05	0.00262	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	9.16e-05	0.00256	CbGpPWpGaD
Bexarotene—Nausea—Timolol—glaucoma	8.94e-05	0.000187	CcSEcCtD
Bexarotene—RXRA—Metabolism—CA1—glaucoma	8.7e-05	0.00243	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CTSA—glaucoma	8.43e-05	0.00236	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.4e-05	0.00235	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CA2—glaucoma	7.96e-05	0.00223	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.95e-05	0.00222	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—CDKN2B—glaucoma	7.8e-05	0.00218	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.78e-05	0.00217	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.78e-05	0.00217	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—glaucoma	7.71e-05	0.00216	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CDKN2B—glaucoma	7.67e-05	0.00214	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP1B1—glaucoma	7.56e-05	0.00211	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	7.46e-05	0.00209	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CDKN2B—glaucoma	7.21e-05	0.00201	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.07e-05	0.00198	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR3C1—glaucoma	6.85e-05	0.00191	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR3C1—glaucoma	6.73e-05	0.00188	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NARFL—glaucoma	6.65e-05	0.00186	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA5A—glaucoma	6.65e-05	0.00186	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.61e-05	0.00185	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR3C1—glaucoma	6.32e-05	0.00177	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.26e-05	0.00175	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—glaucoma	6.05e-05	0.00169	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.96e-05	0.00167	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.67e-05	0.00158	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TXN—glaucoma	5.61e-05	0.00157	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.12e-05	0.00143	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.07e-05	0.00142	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5e-05	0.0014	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.99e-05	0.00139	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.92e-05	0.00138	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—glaucoma	4.58e-05	0.00128	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NARFL—glaucoma	4.39e-05	0.00123	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA5A—glaucoma	4.39e-05	0.00123	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTT1—glaucoma	4.35e-05	0.00122	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.99e-05	0.00111	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.93e-05	0.0011	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CDKN2B—glaucoma	3.76e-05	0.00105	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.51e-05	0.00098	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCA1—glaucoma	3.47e-05	0.000968	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1B1—glaucoma	3.47e-05	0.000968	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—glaucoma	3.44e-05	0.000963	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—glaucoma	3.3e-05	0.000921	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA1—glaucoma	3.25e-05	0.000908	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CTSA—glaucoma	3.15e-05	0.00088	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—glaucoma	3.09e-05	0.000864	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA2—glaucoma	2.97e-05	0.000831	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.9e-05	0.000812	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.9e-05	0.000812	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—glaucoma	2.77e-05	0.000774	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—glaucoma	2.65e-05	0.000741	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—glaucoma	2.45e-05	0.000684	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—glaucoma	2.28e-05	0.000637	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAV1—glaucoma	2.26e-05	0.000631	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA1—glaucoma	2.14e-05	0.000599	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TXN—glaucoma	2.09e-05	0.000585	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CTSA—glaucoma	2.08e-05	0.00058	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA2—glaucoma	1.96e-05	0.000548	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.91e-05	0.000534	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.89e-05	0.000529	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—glaucoma	1.71e-05	0.000477	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—glaucoma	1.62e-05	0.000454	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—glaucoma	1.56e-05	0.000436	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TXN—glaucoma	1.38e-05	0.000386	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.31e-05	0.000366	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1B1—glaucoma	1.29e-05	0.000362	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCA1—glaucoma	1.29e-05	0.000362	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—glaucoma	1.07e-05	0.000299	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—glaucoma	1.03e-05	0.000289	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—glaucoma	9.14e-06	0.000255	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCA1—glaucoma	8.53e-06	0.000238	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1B1—glaucoma	8.53e-06	0.000238	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—glaucoma	8.51e-06	0.000238	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAV1—glaucoma	8.43e-06	0.000236	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—glaucoma	6.82e-06	0.000191	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—glaucoma	6.37e-06	0.000178	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—glaucoma	6.03e-06	0.000168	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—glaucoma	5.83e-06	0.000163	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—glaucoma	5.61e-06	0.000157	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAV1—glaucoma	5.56e-06	0.000155	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—glaucoma	4.2e-06	0.000118	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—glaucoma	3.85e-06	0.000107	CbGpPWpGaD
